Therapeutic Cloning for Parkinson’s Works in Lab Mice

Researchers at Memorial-Sloan-Kettering Cancer Center (MSKCC) have announced a very promising development in the treatment of Parkinson’s disease. They’ve used a process called somatic-cell nuclear transfer (SCNT) in laboratory mice, which led to neurological improvement deemed successful in the treatment of Parkinson’s disease. The research team expressed hope for further studies that might lead to similar cures in humans and in other diseases that affect other organ systems. Read more

-->

Polls

  • Should healthcare professionals, who oppose abortion for moral reasons, be forced to perform the procedure anyway?

    View Results

    Loading ... Loading ...

Editor's Picks

alt text Hope for Mesothelioma Patients May Lie in Recent Genetic Study

A recently published article about the genetic affect of asbestos exposure has offered...

alt text Women Dying To Be Beautiful?

If researchers are right, it may be more than mere coincidence that beauty and pain...

alt text The Cause of Mesothelioma Could be in Your Attic

With energy prices on the rise, homeowners are looking for ways to improve heating...

More Editor's Picks
    End, comment out -->